Ge Healthcare - 2104628-001 - Phototherapy System Led And Fiber Optic Based For Use With Indirect Hyperbilirubinemia In Newborns

Below are the key product attributes and specifications that provide detailed information about this item:

The GE Healthcare - GE - 2104628-001 - Phototherapy System is an advanced LED and fiber optic-based solution designed for the effective treatment of indirect hyperbilirubinemia in newborns. This system delivers targeted phototherapy to reduce bilirubin levels in infants, ensuring safe and efficient care.

Features:
- Utilizes high-intensity LED and fiber optic technology for consistent and uniform light delivery.
- Designed specifically for newborn jaundice treatment, providing optimal wavelength (460-490 nm) for bilirubin breakdown.
- Adjustable intensity settings to customize therapy based on clinical needs.
- Lightweight and portable, allowing easy placement in NICUs, nurseries, or bassinets.
- Minimal heat emission, ensuring patient comfort and safety during prolonged use.
- Durable and long-lasting LED bulbs, reducing maintenance and replacement costs.

Specifications:
- Light Source: LED and fiber optic
- Wavelength Range: 460-490 nm (optimal for bilirubin absorption)
- Power Supply: Standard AC power input
- Weight: Lightweight for easy maneuverability
- Compatibility: Designed for use with newborns in clinical and hospital settings

Use Suggestion:
This phototherapy system is ideal for hospital nurseries, neonatal intensive care units (NICUs), and pediatric care centers. Position the light source at the recommended distance from the infant to ensure effective treatment while monitoring bilirubin levels regularly for optimal results.